Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Paraproteinemic keratopathy in monoclonal gammopathy of undetermined significance treated with primary keratoprosthesis: Case report, histopathologic findings, and world literature review.

Chiang HH, Wieland RS, Rogers TS, Gibson PC, Atweh G, McCormick G.

Medicine (Baltimore). 2017 Dec;96(50):e8649. doi: 10.1097/MD.0000000000008649. Review.

2.

Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain crisis.

Manwani D, Chen G, Carullo V, Serban S, Olowokure O, Jang J, Huggins M, Cohen HW, Billett H, Atweh GF, Frenette PS, Shi PA.

Am J Hematol. 2015 May;90(5):381-5. doi: 10.1002/ajh.23956. Epub 2015 Apr 1.

3.

p27(Kip1) and STMN1: partners again?

Atweh GF, Iancu-Rubin C.

Cell Cycle. 2014;13(20):3163. doi: 10.4161/15384101.2014.966580. No abstract available.

4.

Biomarkers for early detection of sickle nephropathy.

Sundaram N, Bennett M, Wilhelm J, Kim MO, Atweh G, Devarajan P, Malik P.

Am J Hematol. 2011 Jul;86(7):559-66. doi: 10.1002/ajh.22045. Epub 2011 May 31.

5.

Down-regulation of stathmin expression is required for megakaryocyte maturation and platelet production.

Iancu-Rubin C, Gajzer D, Tripodi J, Najfeld V, Gordon RE, Hoffman R, Atweh GF.

Blood. 2011 Apr 28;117(17):4580-9. doi: 10.1182/blood-2010-09-305540. Epub 2011 Mar 1.

6.

Pharmacologic induction of fetal hemoglobin production.

Atweh G, Fathallah H.

Hematol Oncol Clin North Am. 2010 Dec;24(6):1131-44. doi: 10.1016/j.hoc.2010.08.001. Epub 2010 Sep 29. Review.

PMID:
21075284
7.

Hydroxyurea in sickle cell disease: What will it take to change practice?

Atweh GF.

Am J Hematol. 2010 Jun;85(6):401-2. doi: 10.1002/ajh.21733. No abstract available.

8.

Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease.

Fathallah H, Taher A, Bazarbachi A, Atweh GF.

Blood Cells Mol Dis. 2009 Jul-Aug;43(1):58-62. doi: 10.1016/j.bcmd.2009.02.006. Epub 2009 Apr 5.

9.

Histone deacetylase inhibitors and hemoglobin F induction in beta-thalassemia.

Migliaccio AR, Rotili D, Nebbioso A, Atweh G, Mai A.

Int J Biochem Cell Biol. 2008;40(11):2341-7. doi: 10.1016/j.biocel.2008.04.024. Epub 2008 May 29. Review.

10.

Epigenetic analysis of the human alpha- and beta-globin gene clusters.

Fathallah H, Portnoy G, Atweh GF.

Blood Cells Mol Dis. 2008 Mar-Apr;40(2):166-73. Epub 2007 Oct 29.

11.

Synergistic antiangiogenic effects of stathmin inhibition and taxol exposure.

Mistry SJ, Bank A, Atweh GF.

Mol Cancer Res. 2007 Aug;5(8):773-82. Epub 2007 Aug 1.

12.

Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin.

Fathallah H, Weinberg RS, Galperin Y, Sutton M, Atweh GF.

Blood. 2007 Nov 1;110(9):3391-7. Epub 2007 Jul 17.

13.

Sickle cell disease: old discoveries, new concepts, and future promise.

Frenette PS, Atweh GF.

J Clin Invest. 2007 Apr;117(4):850-8. Review.

14.
15.

Induction of fetal hemoglobin in the treatment of sickle cell disease.

Fathallah H, Atweh GF.

Hematology Am Soc Hematol Educ Program. 2006:58-62. Review.

PMID:
17124041
16.

Prevention and management of strokes in patients with sickle cell disease.

Abboud MR, Atweh GF.

Curr Hematol Rep. 2006 Mar;5(1):15-22. Review.

PMID:
16537042
17.

DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.

Fathallah H, Atweh GF.

Blood Rev. 2006 Jul;20(4):227-34. Epub 2006 Mar 2.

PMID:
16513230
18.

Targeting stathmin in prostate cancer.

Mistry SJ, Bank A, Atweh GF.

Mol Cancer Ther. 2005 Dec;4(12):1821-9.

19.

Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?

Fathallah H, Sutton M, Atweh GF.

Ann N Y Acad Sci. 2005;1054:228-37. Review.

PMID:
16339670
20.

Stathmin prevents the transition from a normal to an endomitotic cell cycle during megakaryocytic differentiation.

Iancu-Rubin C, Nasrallah CA, Atweh GF.

Cell Cycle. 2005 Dec;4(12):1774-82. Epub 2005 Dec 13.

PMID:
16258287
21.

p27(Kip1) and stathmin share the stage for the first time.

Iancu-Rubin C, Atweh GF.

Trends Cell Biol. 2005 Jul;15(7):346-8. Review.

PMID:
15951178
22.

Butyrate increases the efficiency of translation of gamma-globin mRNA.

Weinberg RS, Ji X, Sutton M, Perrine S, Galperin Y, Li Q, Liebhaber SA, Stamatoyannopoulos G, Atweh GF.

Blood. 2005 Feb 15;105(4):1807-9. Epub 2004 Oct 12.

23.

The role of stathmin in the regulation of the cell cycle.

Rubin CI, Atweh GF.

J Cell Biochem. 2004 Oct 1;93(2):242-50. Review.

PMID:
15368352
24.

Hemoglobinopathies.

Atweh GF, DeSimone J, Saunthararajah Y, Fathallah H, Weinberg RS, Nagel RL, Fabry ME, Adams RJ.

Hematology Am Soc Hematol Educ Program. 2003:14-39. Review.

PMID:
14633775
25.

Stathmin expression and megakaryocyte differentiation: a potential role in polyploidy.

Rubin CI, French DL, Atweh GF.

Exp Hematol. 2003 May;31(5):389-97.

PMID:
12763137
26.

Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy.

Mistry SJ, Atweh GF.

Mt Sinai J Med. 2002 Oct;69(5):299-304. Review.

PMID:
12415323
27.

Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia.

Atweh GF, Loukopoulos D.

Semin Hematol. 2001 Oct;38(4):367-73. Review.

PMID:
11605172
28.

Stathmin inhibition enhances okadaic acid-induced mitotic arrest: a potential role for stathmin in mitotic exit.

Mistry SJ, Atweh GF.

J Biol Chem. 2001 Aug 17;276(33):31209-15. Epub 2001 Jun 19.

29.

In vivo silencing of the human gamma-globin gene in murine erythroid cells following retroviral transduction.

Lung HY, Meeus IS, Weinberg RS, Atweh GF.

Blood Cells Mol Dis. 2000 Dec;26(6):613-9.

PMID:
11358353
30.

Development of ribozymes that target stathmin, a major regulator of the mitotic spindle.

Mistry SJ, Benham CJ, Atweh GF.

Antisense Nucleic Acid Drug Dev. 2001 Feb;11(1):41-9.

PMID:
11258620
31.

Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease.

Atweh GF, Schechter AN.

Curr Opin Hematol. 2001 Mar;8(2):123-30. Review.

PMID:
11224687
32.

Effects of stathmin inhibition on the mitotic spindle.

Iancu C, Mistry SJ, Arkin S, Wallenstein S, Atweh GF.

J Cell Sci. 2001 Mar;114(Pt 5):909-16.

33.

Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle.

Iancu C, Mistry SJ, Arkin S, Atweh GF.

Cancer Res. 2000 Jul 1;60(13):3537-41.

34.

Resolving conflicts: misconceptions and myths in the care of the patient with sickle cell disease.

Sutton M, Atweh GF, Cashman TD, Davis WT.

Mt Sinai J Med. 1999 Sep;66(4):282-5.

PMID:
10477486
35.

Stathmin expression in immortalized and oncogene transformed cells.

Mistry SJ, Atweh GF.

Anticancer Res. 1999 Jan-Feb;19(1A):573-7.

PMID:
10226601
36.

Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.

Atweh GF, Sutton M, Nassif I, Boosalis V, Dover GJ, Wallenstein S, Wright E, McMahon L, Stamatoyannopoulos G, Faller DV, Perrine SP.

Blood. 1999 Mar 15;93(6):1790-7.

37.

WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts.

Hosono S, Luo X, Hyink DP, Schnapp LM, Wilson PD, Burrow CR, Reddy JC, Atweh GF, Licht JD.

Oncogene. 1999 Jan 14;18(2):417-27.

38.
39.

Role for protein phosphatases in the cell-cycle-regulated phosphorylation of stathmin.

Mistry SJ, Li HC, Atweh GF.

Biochem J. 1998 Aug 15;334 ( Pt 1):23-9.

40.

Cellular and molecular effects of a pulse butyrate regimen and new inducers of globin gene expression and hematopoiesis.

Ikuta T, Atweh G, Boosalis V, White GL, Da Fonseca S, Boosalis M, Faller DV, Perrine SP.

Ann N Y Acad Sci. 1998 Jun 30;850:87-99. Review.

PMID:
9668531
41.

Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells.

Jeha S, Luo XN, Beran M, Kantarjian H, Atweh GF.

Cancer Res. 1996 Mar 15;56(6):1445-50.

44.

The tumor suppressor gene WT1 inhibits ras-mediated transformation.

Luo XN, Reddy JC, Yeyati PL, Idris AH, Hosono S, Haber DA, Licht JD, Atweh GF.

Oncogene. 1995 Aug 17;11(4):743-50.

PMID:
7651738
45.
46.

Increased expression of the G gamma and A gamma globin genes associated with a mutation in the A gamma enhancer.

Balta G, Brickner HE, Takegawa S, Kazazian HH Jr, Papayannopoulou T, Forget BG, Atweh GF.

Blood. 1994 Jun 15;83(12):3727-37.

47.

Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase.

Luo XN, Mookerjee B, Ferrari A, Mistry S, Atweh GF.

J Biol Chem. 1994 Apr 8;269(14):10312-8.

48.
49.
50.

Spontaneous delta- to beta-globin switching in K562 human leukemia cells.

Mookerjee B, Arcasoy MO, Atweh GF.

Blood. 1992 Feb 1;79(3):820-5.

Supplemental Content

Support Center